Tiotropium / Respimat One-Year Study
NCT00168844
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
983
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
Tiotropium Inhalation Solution
OTHER:
Placebo
Sponsor
Boehringer Ingelheim